Who
Scott Dreyer
EVP & Chief Commercial Officer
Company insider
Files Form 4 as: EVP & Chief Commercial Officer, Collegium Pharmaceutical.
In numbers
- Trades disclosed
- 90
- Buys
- 0
- Sells
- 26
- Bought
- $0
- Sold
- $14.1M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 10 Jul 2018
- Last trade
- 3 Mar 2026
- Last filed
- 5 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Mar 2026filed 5 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $1.9M46,417 at $40.36 | filing |
| 3 Mar 2026filed 5 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $146K3,559 at $40.99 | filing |
| 3 Mar 2026filed 5 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $1.9M46,417 at $40.36 | filing |
| 3 Mar 2026filed 5 Mar 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $146K3,559 at $40.99 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —19,023 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —30,702 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $466K9,977 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $1.0M21,615 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —19,023 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code A | —30,702 at $0.00 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $466K9,977 at $46.75 | filing |
| 10 Feb 2026filed 12 Feb 2026 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code F | $1.0M21,615 at $46.75 | filing |
| 8 Dec 2025filed 10 Dec 2025 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —17,600 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $280K17,600 at $15.90 | filing |
| 8 Dec 2025filed 10 Dec 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $533K11,125 at $47.89 | filing |
| 8 Dec 2025filed 10 Dec 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $315K6,475 at $48.66 | filing |
| 18 Aug 2025filed 20 Aug 2025 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —16,389 at $0.00 | filing |
| 18 Aug 2025filed 20 Aug 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Code M | $350K16,389 at $21.34 | filing |
| 18 Aug 2025filed 20 Aug 2025 | COLL Collegium PharmaceuticalPharmaceuticals | SEC FORM 4 Sold | $626K16,389 at $38.21 | filing |
| 13 Aug 2025filed 15 Aug 2025 | COLL Collegium Pharmaceuticaloption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —4,861 at $0.00 | filing |
News
Head to Head Survey: Collegium Pharmaceutical (NASDAQ:COLL) versus Journey Medical (NASDAQ:DERM)COLL · dailypolitical.com · 22 Oct 2026Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stock Has Consensus Price Target of $48.71COLL · dailypolitical.com · 13 Oct 2026
0 headlines in the last 90 days name Scott Dreyer; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.